1 of 25

2 of 25

CE

3 of 25

V$E2F_Q6 PWM cut-offs

%

FP

FN

4 of 25

human TNFα promoter

mast cells

T-cells + ?

dendritic cells

T-cells

-107

-74

NFAT

NFAT

AP-1

NF-kB

C/EBP

AP-1

VDR

5 of 25

TRANSFAC – experimentally proven TF binding sites

6 of 25

7 of 25

organ,

tissue,

cell

stage of

development

cell cycle

phase

extracellular

signals

TF combinations encode gene expression pattern

8 of 25

9 of 25

Composite elements (CE)

Minimal functional units where both protein-DNA and protein-protein

interactions contribute to a highly specific pattern of gene expression

and provide cross-coupling of different signal transduction pathways.

tgccacacaggtagactcttTTGAAAATAtgTGTAATAtgtaaaa catcgtgaca cccccatatt… …

. . . . . . .

-96

-79

ST

COMPEL:C00050

NF-ATp

AP-1

Mouse Interleukin-2

gene promoter

TGAGTCA

AP-1 consensus

10 of 25

11 of 25

12 of 25

V$<cluster4>

Studied tissue: liver

Nrf2

NFe2l1

Bach1

Bach2

NF-E2p45

Nrf3

49.3

18.4

17.6

5.8

2.6

2.3

Expression values

13 of 25

V$<cluster4>

Studied tissue: liver

Nrf2

Nrf3

16.6

-3.5

-4.4

-2.0

3.8

0.1

Bach1

Bach2

NF-E2p45

NFe2l1

Expression diff from average

0,01418

0,07975

0,03902

0,10333

0,36808

0,13904

Tissue specificity

Tissue preference

≤0.014

≤0.019

≤0.025

≤0.031

≤0.045

≤0.07

≤0.13

≤0.23

≤0.4

≤1.0

14 of 25

V$<cluster22>

Studied tissue: liver

SREBP1

USF2

SREBP2

USF1

TFEA

TFEB

TFEC

MITF

49.9

47.9

20.4

19.1

14.1

5.0

2.8

1.8

Expression values

15 of 25

V$<cluster22>

Studied tissue: liver

SREBP1

USF2

USF1

TFEA

33.2

13.3

-3.6

-6.2

-7.9

2.8

-2.2

-2.4

TFEC

TFEB

SREBP2

MITF

Tissue preference

Expression diff from average

≤0.014

≤0.019

≤0.025

≤0.031

≤0.045

≤0.07

≤0.13

≤0.23

≤0.4

≤1.0

16 of 25

V$<cluster16>

Studied tissue: liver

HAND2

Dermo-1

EC2

TWIST

FIGLA

Scx

EHAND

PTF1

8.2

0

0.3

0.3

0.3

0.1

0.1

0.1

Expression values

17 of 25

V$<cluster16>

Studied tissue: pancreas

PTF1

HAND2

FIGLA

Scx

Dermo-1

TWIST

EC2

EHAND

129.8

3.8

2.8

0.1

2.8

0.7

0.4

0.1

Expression values

18 of 25

V$<cluster16>

Studied tissue: liver

FIGLA

HAND2

EC2

PTF1

-2.4

-4.6

-4.9

-1.3

-2.2

-2.3

EHAND

Dermo-1

Scx

TWIST

Tissue preference

-1.1

-0.3

Expression diff from average

≤0.014

≤0.019

≤0.025

≤0.031

≤0.045

≤0.07

≤0.13

≤0.23

≤0.4

≤1.0

19 of 25

V$<cluster16>

Studied tissue: pancreas

-4.5

-4.5

-5.5

0.3

-1.5

-2.3

≤0.014

≤0.019

≤0.025

≤0.031

≤0.045

≤0.07

≤0.13

≤0.23

≤0.4

≤1.0

Tissue preference

2.4

127.6

PTF1

FIGLA

Scx

EC2

EHAND

TWIST

Dermo-1

HAND2

Expression diff from average

20 of 25

Phylogenetic footprint

(human/mouse)

Spec1

Spec2

21 of 25

The result of applying of the “Phylogenetic Footprint” tool to the proximal part of the human/mouse PTH CNS3. The beginning of the fist exon in both sequences is marked by a shadow. Two sites are marked (CREB and VDRE) that have been described previously for this region in human PTH gene. Conservative sites found by this analysis are shown by the arrows above each sequence. A number of new potential sites is revealed: CREB site, OCT site near start of transcription, a couple of NF-AT sites, SP-1 sites, GATA sites and some others

22 of 25

Alignment of c-fos promoters

23 of 25

Spec1

Spec2

Phylogenetic anti-footprint

(human/chimp)

24 of 25

25 of 25

Examples of anti-footprint (human/chimp) (minimized FP)